In vivo evaluation of a MPC polymer coated continuous flow left ventricular assist system

Shin'ichiro Kihara, Kenji Yamazaki, Kenneth N. Litwak, Philip Litwak, Marina V. Kameneva, Hiroyuki Ushiyama, Toshimasa Tokuno, David C. Borzelleca, Mitsuo Umezu, Jun Tomioka, Osamu Tagusari, Takehide Akimoto, Hitoshi Koyanagi, Hiromi Kurosawa, Robert L. Kormos, Bartley P. Griffith

    Research output: Contribution to journalArticle

    57 Citations (Scopus)

    Abstract

    The aim of this study was the evaluation of the thrombogenicity and the biocompatibility of the SunMedical EVAHEART left ventricular assist system (LVAS) coated with 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer compared to a diamond-like carbon (DLC) coating. Four calves were implanted with the MPC polymer-coated LVAS. Eight calves were implanted with DLC coated LVAS. The thrombogenicity and biocompatibility of the pumps were evaluated. At explant, 60.0 ± 37.2% (5-85%) of the pump surface area was still coated with MPC polymer after the duration of 45.0 ± 32.0 days. In 1 out of 4 MPC and 2 out of 8 DLC coated pumps, there was a very small amount of thrombus around the seal ring; otherwise the blood contacting surfaces were free of thrombus. Major organs were normal except for a few lesions in kidneys from both groups. The MPC polymer coated EVAHEART LVAS seems to have low thrombogenicity and high biocompatibility similar to the DLC coated system. The current study demonstrated that the MPC polymer coating shows great promise for being used as an antithrombogenic substrate for the LVAS due to its ease of application, significant cost benefit, and reduction in anticoagulation therapy in acute postoperative period.

    Original languageEnglish
    Pages (from-to)188-192
    Number of pages5
    JournalArtificial Organs
    Volume27
    Issue number2
    DOIs
    Publication statusPublished - 2003 Feb 1

    Fingerprint

    Phosphorylcholine
    Diamond
    Polymers
    Diamonds
    Carbon
    Biocompatibility
    Pumps
    Thrombosis
    Coatings
    Postoperative Period
    Cost-Benefit Analysis
    Seals
    Blood
    Kidney
    Substrates
    Costs

    Keywords

    • 2-methacryloyloxyethyl phosphorylcholine
    • Biocompatibility
    • Diamond-like carbon
    • Left ventricular assist device
    • Rotary blood pump
    • Thrombogenicity

    ASJC Scopus subject areas

    • Biophysics

    Cite this

    Kihara, S., Yamazaki, K., Litwak, K. N., Litwak, P., Kameneva, M. V., Ushiyama, H., ... Griffith, B. P. (2003). In vivo evaluation of a MPC polymer coated continuous flow left ventricular assist system. Artificial Organs, 27(2), 188-192. https://doi.org/10.1046/j.1525-1594.2003.t01-2-06993.x

    In vivo evaluation of a MPC polymer coated continuous flow left ventricular assist system. / Kihara, Shin'ichiro; Yamazaki, Kenji; Litwak, Kenneth N.; Litwak, Philip; Kameneva, Marina V.; Ushiyama, Hiroyuki; Tokuno, Toshimasa; Borzelleca, David C.; Umezu, Mitsuo; Tomioka, Jun; Tagusari, Osamu; Akimoto, Takehide; Koyanagi, Hitoshi; Kurosawa, Hiromi; Kormos, Robert L.; Griffith, Bartley P.

    In: Artificial Organs, Vol. 27, No. 2, 01.02.2003, p. 188-192.

    Research output: Contribution to journalArticle

    Kihara, S, Yamazaki, K, Litwak, KN, Litwak, P, Kameneva, MV, Ushiyama, H, Tokuno, T, Borzelleca, DC, Umezu, M, Tomioka, J, Tagusari, O, Akimoto, T, Koyanagi, H, Kurosawa, H, Kormos, RL & Griffith, BP 2003, 'In vivo evaluation of a MPC polymer coated continuous flow left ventricular assist system', Artificial Organs, vol. 27, no. 2, pp. 188-192. https://doi.org/10.1046/j.1525-1594.2003.t01-2-06993.x
    Kihara, Shin'ichiro ; Yamazaki, Kenji ; Litwak, Kenneth N. ; Litwak, Philip ; Kameneva, Marina V. ; Ushiyama, Hiroyuki ; Tokuno, Toshimasa ; Borzelleca, David C. ; Umezu, Mitsuo ; Tomioka, Jun ; Tagusari, Osamu ; Akimoto, Takehide ; Koyanagi, Hitoshi ; Kurosawa, Hiromi ; Kormos, Robert L. ; Griffith, Bartley P. / In vivo evaluation of a MPC polymer coated continuous flow left ventricular assist system. In: Artificial Organs. 2003 ; Vol. 27, No. 2. pp. 188-192.
    @article{ef84edd7d1b74039b47e6365d0780d14,
    title = "In vivo evaluation of a MPC polymer coated continuous flow left ventricular assist system",
    abstract = "The aim of this study was the evaluation of the thrombogenicity and the biocompatibility of the SunMedical EVAHEART left ventricular assist system (LVAS) coated with 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer compared to a diamond-like carbon (DLC) coating. Four calves were implanted with the MPC polymer-coated LVAS. Eight calves were implanted with DLC coated LVAS. The thrombogenicity and biocompatibility of the pumps were evaluated. At explant, 60.0 ± 37.2{\%} (5-85{\%}) of the pump surface area was still coated with MPC polymer after the duration of 45.0 ± 32.0 days. In 1 out of 4 MPC and 2 out of 8 DLC coated pumps, there was a very small amount of thrombus around the seal ring; otherwise the blood contacting surfaces were free of thrombus. Major organs were normal except for a few lesions in kidneys from both groups. The MPC polymer coated EVAHEART LVAS seems to have low thrombogenicity and high biocompatibility similar to the DLC coated system. The current study demonstrated that the MPC polymer coating shows great promise for being used as an antithrombogenic substrate for the LVAS due to its ease of application, significant cost benefit, and reduction in anticoagulation therapy in acute postoperative period.",
    keywords = "2-methacryloyloxyethyl phosphorylcholine, Biocompatibility, Diamond-like carbon, Left ventricular assist device, Rotary blood pump, Thrombogenicity",
    author = "Shin'ichiro Kihara and Kenji Yamazaki and Litwak, {Kenneth N.} and Philip Litwak and Kameneva, {Marina V.} and Hiroyuki Ushiyama and Toshimasa Tokuno and Borzelleca, {David C.} and Mitsuo Umezu and Jun Tomioka and Osamu Tagusari and Takehide Akimoto and Hitoshi Koyanagi and Hiromi Kurosawa and Kormos, {Robert L.} and Griffith, {Bartley P.}",
    year = "2003",
    month = "2",
    day = "1",
    doi = "10.1046/j.1525-1594.2003.t01-2-06993.x",
    language = "English",
    volume = "27",
    pages = "188--192",
    journal = "Artificial Organs",
    issn = "0160-564X",
    publisher = "Wiley-Blackwell",
    number = "2",

    }

    TY - JOUR

    T1 - In vivo evaluation of a MPC polymer coated continuous flow left ventricular assist system

    AU - Kihara, Shin'ichiro

    AU - Yamazaki, Kenji

    AU - Litwak, Kenneth N.

    AU - Litwak, Philip

    AU - Kameneva, Marina V.

    AU - Ushiyama, Hiroyuki

    AU - Tokuno, Toshimasa

    AU - Borzelleca, David C.

    AU - Umezu, Mitsuo

    AU - Tomioka, Jun

    AU - Tagusari, Osamu

    AU - Akimoto, Takehide

    AU - Koyanagi, Hitoshi

    AU - Kurosawa, Hiromi

    AU - Kormos, Robert L.

    AU - Griffith, Bartley P.

    PY - 2003/2/1

    Y1 - 2003/2/1

    N2 - The aim of this study was the evaluation of the thrombogenicity and the biocompatibility of the SunMedical EVAHEART left ventricular assist system (LVAS) coated with 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer compared to a diamond-like carbon (DLC) coating. Four calves were implanted with the MPC polymer-coated LVAS. Eight calves were implanted with DLC coated LVAS. The thrombogenicity and biocompatibility of the pumps were evaluated. At explant, 60.0 ± 37.2% (5-85%) of the pump surface area was still coated with MPC polymer after the duration of 45.0 ± 32.0 days. In 1 out of 4 MPC and 2 out of 8 DLC coated pumps, there was a very small amount of thrombus around the seal ring; otherwise the blood contacting surfaces were free of thrombus. Major organs were normal except for a few lesions in kidneys from both groups. The MPC polymer coated EVAHEART LVAS seems to have low thrombogenicity and high biocompatibility similar to the DLC coated system. The current study demonstrated that the MPC polymer coating shows great promise for being used as an antithrombogenic substrate for the LVAS due to its ease of application, significant cost benefit, and reduction in anticoagulation therapy in acute postoperative period.

    AB - The aim of this study was the evaluation of the thrombogenicity and the biocompatibility of the SunMedical EVAHEART left ventricular assist system (LVAS) coated with 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer compared to a diamond-like carbon (DLC) coating. Four calves were implanted with the MPC polymer-coated LVAS. Eight calves were implanted with DLC coated LVAS. The thrombogenicity and biocompatibility of the pumps were evaluated. At explant, 60.0 ± 37.2% (5-85%) of the pump surface area was still coated with MPC polymer after the duration of 45.0 ± 32.0 days. In 1 out of 4 MPC and 2 out of 8 DLC coated pumps, there was a very small amount of thrombus around the seal ring; otherwise the blood contacting surfaces were free of thrombus. Major organs were normal except for a few lesions in kidneys from both groups. The MPC polymer coated EVAHEART LVAS seems to have low thrombogenicity and high biocompatibility similar to the DLC coated system. The current study demonstrated that the MPC polymer coating shows great promise for being used as an antithrombogenic substrate for the LVAS due to its ease of application, significant cost benefit, and reduction in anticoagulation therapy in acute postoperative period.

    KW - 2-methacryloyloxyethyl phosphorylcholine

    KW - Biocompatibility

    KW - Diamond-like carbon

    KW - Left ventricular assist device

    KW - Rotary blood pump

    KW - Thrombogenicity

    UR - http://www.scopus.com/inward/record.url?scp=0344838635&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0344838635&partnerID=8YFLogxK

    U2 - 10.1046/j.1525-1594.2003.t01-2-06993.x

    DO - 10.1046/j.1525-1594.2003.t01-2-06993.x

    M3 - Article

    VL - 27

    SP - 188

    EP - 192

    JO - Artificial Organs

    JF - Artificial Organs

    SN - 0160-564X

    IS - 2

    ER -